Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway

Journal of Cell Biology

Volumn 161, Issue 1, 2003, Pages 111-118

  Horsley, Valerie ^a,b   Pavlath, Grace K ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Cell fusion; FP receptor; Myonuclei; NSAIDS

Indexed keywords

CALCIUM; ISOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; DNA BINDING PROTEIN; DRUG DERIVATIVE; GROWTH PROMOTOR; NFATC2 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROSTAGLANDIN F2ALPHA RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL ASSAY; CELL FUSION; CELL GROWTH; CELL LINE; CELL SIZE; CELLULAR PARAMETERS; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; MOUSE; MULTINUCLEAR CELL; MUSCLE CELL; MUSCLE GROWTH; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; T LYMPHOCYTE ACTIVATION; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; CALCIUM SIGNALING; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALIA;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL SIZE; CELLS, CULTURED; DINOPROST; DNA-BINDING PROTEINS; GROWTH SUBSTANCES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUSCLE FIBERS; MUSCLE, SKELETAL; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0037437175     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200208085     Document Type: Article

References (65)

1. Abbott, K.L., B.B. Friday, D. Thaloor, T.J. Murphy, and G.K. Pavlath. 1998. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell. 9:2905-2916.
2. Adams, J.W., D.S. Migita, M.K. Yu, R. Young, M.S. Hellickson, F.E. Castro-Vargas, J.D. Domingo, P.H. Lee, J.S. Bui, and S.A. Henderson. 1996. Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J. Biol Chem. 271:1179-1186.
3. Allen, D.L., R.R. Roy, and V.R. Edgerton. 1999. Myonuclear domains in muscle adaptation and disease. Muscle Nerve. 22:1350-1360.
4. Aramburu, J., M.B. Yaffe, C. Lopez-Rodriguez, L.C. Cantley, P.G. Hogan, and A. Rao. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science. 285:2129-2133.
5. Asboth, G., S. Phaneuf, G.N. Europe-Finner, M. Toth, and A.L. Bernal. 1996. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes. Endocrinology 137:2572-2579.
6. Barnoy, S., T. Glasner, and N.S. Kosower. 1996. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220:933-938.
7. Barton-Davis, E.R., D.I. Shoturma, and H.L. Sweeney. 1999. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol. Scand. 167:301-305.
8. Bate, M. 1990. The embryonic development of larval muscles in Drosophila. Development. 110:791-804.
9. Breyer, R.M., C.K. Bagdassarian, S.A. Myers, and M.D. Breyer. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:661-690.
10. Chen, W., T. Andom, P. Bhattacherjee, and C. Paterson. 1997. Intracellular calcium mobilization following prostaglandin receptor activation in human ciliary muscle cells. Curr. Eye Res. 16:847-853.
11. Darr, K.C., and E. Schultz. 1989. Hindlimb suspension suppresses'muscle growth and satellite cell proliferation. J. Appl. Physiol. 67:1827-1834.
12. David, J.D., and C.A. Higginbotham. 1981. Fusion of chick embryo skeletal myoblasts: interactions of prostaglandin E1, adenosine 3′:5′ monophosphate, and calcium influx. Dev. Biol. 82:308-316.
13. Delling, U., J. Tureckova, H.W. Lim, L.J. De Windt, P. Rotwein, and J.D. Molkentin. 2000. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol. Cell. Biol. 20:6600-6611.
14. Dorn, G.W. II, M.W. Becker, and M.G. Davis. 1992. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J. Biol. Chem. 267:24897-24905.
15. Dunn, S.E., J.L. Burns, and R.N. Michel. 1999. Calcineurin is required for skeletal muscle hypertrophy. J. Biol. Chem. 274:21908-21912.
16. Entwistle, A., D.H. Curtis, and R.J. Zalin. 1986. Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP. J. Cell Biol. 103:857-866.
17. Friday, B.B., and G.K. Pavlath. 2001. A calcineurin- and NFAT-dependent pathway regulates Myf5 gene expression in skeletal muscle reserve cells. J. Cell Sci. 114:303-310.
18. Friday, B.B., V. Horsley, and G.K. Pavlath. 2000. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J. Cell Biol. 149:657-666.
19. Funk, C.D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294:1871-1875.
20. Gorza, L., and M. Vitadello. 2000. Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J 14:461-475.
21. Griffin, B.W., P.E. Magnino, I.H. Pang, and N.A. Sharif. 1998. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J. Pharmacol. Exp. Ther. 286:411-418.
22. Griffin, B.W., P. Klimko, J.Y. Crider, and N.A. Sharif. 1999. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J. Pharmacol. Exp. Ther. 290:1278-1284.
23. Horsley, V., and G.K. Pavlath. 2002. NFAT: ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 156:771-774.
24. Horsley, V., B.B. Friday, S. Matteson, K.M. Kegley, J. Gephart, and G.K. Pavlath. 2001. Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153:329-338.
25. Katsuyama, M., C. Fan, and C. Yabe-Nishimura. 2002. NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. J. Biol. Chem. 277:13438-13442.
26. Kegley, K.M., J. Gephart, G.L. Warren, and G.K. Pavlath. 2001. Altered primary myogenesis in NFATC3(-/-) mice leads to decreased muscle size in the adult. Dev. Biol. 232:115-126.
27. Knudsen, K.A. 1992. Membrane fusion. In Membrane Fusion. J. Wilschut and D. Hoekstra, editors. Marcel Dekker, Inc., New York. 601-626.
28. Knudsen, K.A., and A.F. Horwitz. 1977. Tandem events in myoblast fusion. Dev. Biol. 58:328-338.
29. Kubis, H.P., R.J. Scheibe, J.D. Meissner, G. Hornung, and G. Gros. 2002. Fast-to-slow transformation and nuclear import/export kinetics of the transcription factor NFATcl during electrostimulation of rabbit muscle cells in culture. J. Physiol. 541:835-847.
30. Kunapuli, P., J.A. Lawson, J.A. Rokach, J.L. Meinkoth, and G.A. FitzGerald. 1998. Prostaglandin F2α (PGF2α) and the isoprostane, 8, 12-iso-isoprostane F2α-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. J. Biol. Chem. 273:22442-22452.
31. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344-352.
32. Lai, J., H. Jin, R. Yang, J. Winer, W. Li, R. Yen, K.L. King, F. Zeigler, A. Ko, J. Cheng, et al. 1996. Prostaglandin Prostagiandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am. J. Physiol. 271:H2197-H2208.
33. Lake, S., H. Gullberg, J. Wahlqvist, A.M. Sjogren, A. Kinhult, P. Lind, E. Hellstrom-Lindahl, and J. Stjernschantz. 1994. Cloning of the rat and human prostaglandin F2 alpha receptors and the expression of the rat prostaglandin F2 alpha receptor. FEBS Lett. 355:317-325.
34. Liu, Y., Z. Cseresnyes, W.R. Randall, and M.F. Schneider. 2001. Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. J. Cell Biol. 155:27-39.
35. McLennan, I.S. 1987. Hormonal regulation of myoblast proliferation and myotube production in vivo: infiuence of Prostaglandins. J. Exp. Zool. 241:237-245.
36. Mishra, D.K., J. Friden, M.C. Schmitz, and R.L. Lieber. 1995. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J. Bone Joint Surg. Am. 77:1510-1519.
37. Mitchell, P.O., and G.K. Pavlath. 2001. A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy. Am. J. Physiol. Cell Physiol. 281:C1706-C1715.
38. Mitchell, P.O., S.T. Mills, and G.K. Pavlath. 2002. Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles. Am. J. Cell Physiol. 282:C984-C992.
39. Morris, G.E., and R.J. Cole. 1979. Calcium and the control of muscle-specific creatine kinase accumulation during skeletal muscle differentiation in vitro. Dev. Biol. 69:146-158.
40. Musaro, A., K.J. McCullagh, F.J. Naya, E.N. Olson, and N. Rosenthal. 1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATcl. Nature. 400:581-585.
41. Palmer, R.M. 1990. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot. Essent. Fatty Acids. 39:95-104.
42. Pavlath, G.K., D. Thaloor, T.A. Rando, M. Cheong, A.W. English, and B. Zheng. 1998. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev. Dyn. 212:495-508.
43. Phelan, J.N., and W.J. Gonyea. 1997. Effect of radiation on satellite cell activity and protein expression in overloaded mammalian skeletal muscle. Anat. Rec. 247:179-188.
44. Pierce, K.L., T.J. Bailey, P.B. Hoyer, D.W. Gil, D.F. Woodward, and J.W. Regan. 1997. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J. Biol. Chem. 272:883-887.
45. Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol., 125:1275-1287.
46. Ranger, A.M., L.C. Gerstenfeld, J. Wang, T. Kon, H. Bae, E.M. Gravallese, M.J. Glimcher, and L.H. Glimcher. 2000. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 191:9-22.
47. Rau, A., D. Buttgereit, A. Holz, R. Fetter, S.K., Doberstein, A. Paululat, N. Staudt, J. Skeath, A.M. Michelson, and R. Renkawitz-Pohl. 2001. Rolling pebbles (rols) is required in Drosophila muscle precursors for recruitment of myoblasts for fusion. Development. 128:5061-5073.
48. Rodemann, H.P., and A.L. Goldberg. 1982. Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 257:1632-1638.
49. Rosenblatt, J.D., and D.J. Parry. 1992. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle. J. Appl. Physiol. 73:2538-2543.
50. Rossi, M.J., M.A. Clark, and S.M. Steiner. 1989. Possible role of prostaglandins in the regulation of mouse myoblasts. J Cell Physiol. 141:142-147.
51. Schutzle, U.B., M.J. Wakelam, and D. Pette. 1984. Prostaglandins and cyclic AMP stimulate creatine kinase synthesis but not fusion in cultured embryonic chick muscle cells. Biochim. Biophys. Acta. 805:204-210.
52. Semsarian, C., M.J. Wu, Y.K. Ju, T. Marciniec, T. Yeoh, D.G. Allen, R.P. Harvey, and R.M. Graham. 1999. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature. 400:576-581.
53. Shainberg, A., G. Yagil, and D. Yaffe. 1969. Control of myogenesis in vitro by Ca2+ concentration in nutritional medium. Exp. CellRes. 58:163-167.
54. Simon, A., M.B. Manigrasso, and J.P. O'Connor. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17:963-976.
55. Templeton, G.H., M. Padalino, and R. Moss. 1986. Influences of inactivity and indomethacin on soleus phosphatidylethanolamine and size. Prostaglandins. 31:545-559.
56. Trappe, T.A., J.D. Fluckey, F. White, C.P. Lambert, and W.J. Evans. 2001. Skeletal muscle PGF(2α) and PGE(2) in response to eccentric resistance exercise: influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metab. 86:5067-5070.
57. Vandenburgh, H.H., S. Hatfaludy, I. Sohar, and J. Shansky. 1990. Stretchinduced prostaglandins and protein turnover in cultured skeletal muscle. Am. J. Physiol. 259:C232-C240.
58. Vandenburgh, H.H., J. Shansky, R. Solerssi, and J. Chromiak. 1995. Mechanical stimulation of skeletal muscle increases prostaglandin F2 alpha production, cyclooxygenase activity, and cell growth by a pertussis toxin sensitive mechanism. J. Cell. Physiol. 163:285-294.
59. Wakelam, M.J. 1985. The fusion of myoblasts. Biochem. J. 228:1-12.
60. Yagami-Hiromasa, T., T. Sato, T. Kurisaki, K. Kamijo, Y. Nabeshima, and A. Fujisawa-Sehara. 1995. A metalloprotease-disintegrin participating in myoblast fusion. Nature. 377:652-656 (see comments).
61. Yew, S.F., K.A. Reeves, and B. Woodward. 1998. Effects of prostaglandin F2 α on intracellular pH, intracellular calcium, cell shortening and L-type calcium currents in rat myocytes. Cardiovasc. Res. 40:538-545.
62. Yousufzai, S.Y., and A.A. Abdel-Latif. 1998. Tyrosine kinase inhibitors suppress prostaglandin F2α-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle. Eur. J. Pharmacol. 360:185-193.
63. Zalin, R.J. 1977. Prostaglandins and myoblast fusion. Dev. Biol. 59:241-248.
64. Zalin, R.J. 1987. The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblasts. Exp. Cell Res. 172:265-281.
65. Zhang, X., E.M. Schwarz, D.A. Young, J.E. Puzas, R.N. Rosier, and R.J. O'Keefe. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109:1405-1415.